Table 1.
Category | Bevacizumab + CCNU | Bevacizumab alone |
---|---|---|
# Previous recurrence | ||
1st | 25 (71.4%) | 24 (66.7%) |
2nd | 10 (28.7%) | 12 (33.3%) |
Age | ||
≤ 50 | 13 (37.1%) | 13 (36.1%) |
> 50 | 22 (62.9%) | 23 (63.9%) |
KPS | ||
60-80 | 11 (31.4%) | 13 (36.1%) |
90-100 | 24 (68.6%) | 23 (63.9%) |
Gender | ||
Male | 11 (31.4%) | 12 (33.3%) |
Female | 24 (68.6%) | 24 (66.7%) |